Pharma & Healthcare
Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 962
- Pages: 110
- Figures: 145
- Views: 24
Phosphodiesterase type 5 inhibitor (PDE5 inhibitor) is a drug used to block degradation of cgmp-specific phosphodiesterase type 5 (PDE5) loop GMP in smooth muscle cell lining supplying blood vessels to various tissues.These drugs dilate the cavernous penis, promote erections with sexual stimulation, and are used to treat erectile dysfunction (ED).Sildenafil is the first effective oral therapy for ED.Because PDE5 is also present in the wall of the smooth muscle arterioles of the inner lung, sildenafil and tadalafil dilate these vessels and are FDA approved for the treatment of pulmonary hypertension.
Market Analysis and Insights: Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market
The global Phosphodiesterase Type 5 (PDE5) Inhibitor market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Phosphodiesterase Type 5 (PDE5) Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Phosphodiesterase Type 5 (PDE5) Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Phosphodiesterase Type 5 (PDE5) Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Phosphodiesterase Type 5 (PDE5) Inhibitor include Eli Lilly, Pfizer, Bayer, Novartis AG, Merck, GlaxoSmithKline plc, Roche, AstraZeneca and BaiYunShan General Factory, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Phosphodiesterase Type 5 (PDE5) Inhibitor is widely used in various fields, such as Hospital, Retail Pharmacy, Online Pharmacies and Other, etc. Hospital provides greatest supports to the Phosphodiesterase Type 5 (PDE5) Inhibitor industry development. In 2023, global % revenue of Phosphodiesterase Type 5 (PDE5) Inhibitor went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Phosphodiesterase Type 5 (PDE5) Inhibitor market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Phosphodiesterase Type 5 (PDE5) Inhibitor, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Phosphodiesterase Type 5 (PDE5) Inhibitor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Phosphodiesterase Type 5 (PDE5) Inhibitor revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Phosphodiesterase Type 5 (PDE5) Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Phosphodiesterase Type 5 (PDE5) Inhibitor revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Eli Lilly
Pfizer
Bayer
Novartis AG
Merck
GlaxoSmithKline plc
Roche
AstraZeneca
BaiYunShan General Factory
SK Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
Vectura Group
Segment by Type
Sildenafil
Tadalafil
Avanafil
Vardenafil
Segment by Application
Hospital
Retail Pharmacy
Online Pharmacies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Phosphodiesterase Type 5 (PDE5) Inhibitor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phosphodiesterase Type 5 (PDE5) Inhibitor companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phosphodiesterase Type 5 (PDE5) Inhibitor revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market
The global Phosphodiesterase Type 5 (PDE5) Inhibitor market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Phosphodiesterase Type 5 (PDE5) Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Phosphodiesterase Type 5 (PDE5) Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Phosphodiesterase Type 5 (PDE5) Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Phosphodiesterase Type 5 (PDE5) Inhibitor include Eli Lilly, Pfizer, Bayer, Novartis AG, Merck, GlaxoSmithKline plc, Roche, AstraZeneca and BaiYunShan General Factory, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Phosphodiesterase Type 5 (PDE5) Inhibitor is widely used in various fields, such as Hospital, Retail Pharmacy, Online Pharmacies and Other, etc. Hospital provides greatest supports to the Phosphodiesterase Type 5 (PDE5) Inhibitor industry development. In 2023, global % revenue of Phosphodiesterase Type 5 (PDE5) Inhibitor went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Phosphodiesterase Type 5 (PDE5) Inhibitor market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Phosphodiesterase Type 5 (PDE5) Inhibitor, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Phosphodiesterase Type 5 (PDE5) Inhibitor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Phosphodiesterase Type 5 (PDE5) Inhibitor revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Phosphodiesterase Type 5 (PDE5) Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Phosphodiesterase Type 5 (PDE5) Inhibitor revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Eli Lilly
Pfizer
Bayer
Novartis AG
Merck
GlaxoSmithKline plc
Roche
AstraZeneca
BaiYunShan General Factory
SK Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
Vectura Group
Segment by Type
Sildenafil
Tadalafil
Avanafil
Vardenafil
Segment by Application
Hospital
Retail Pharmacy
Online Pharmacies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Phosphodiesterase Type 5 (PDE5) Inhibitor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phosphodiesterase Type 5 (PDE5) Inhibitor companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phosphodiesterase Type 5 (PDE5) Inhibitor revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Avanafil
1.2.5 Vardenafil
1.3 Market by Application
1.3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Perspective (2019-2030)
2.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Trends by Region
2.2.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Region (2019-2024)
2.2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (2025-2030)
2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Dynamics
2.3.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Trends
2.3.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
2.3.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
2.3.4 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Phosphodiesterase Type 5 (PDE5) Inhibitor by Players
3.1.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (2019-2024)
3.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Players (2019-2024)
3.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio
3.4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2023
3.5 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor Head office and Area Served
3.6 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Product and Application
3.7 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Type
4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Type (2019-2024)
4.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2025-2030)
5 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Application
5.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Application (2019-2024)
5.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
6.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
6.2.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
6.2.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
6.2.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
6.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
6.3.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
6.3.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
6.3.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
6.4 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
6.4.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024)
6.4.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
7.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
7.2.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
7.2.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
7.2.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
7.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
7.3.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
7.3.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
7.3.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
7.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
7.4.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024)
7.4.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
8.2 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
8.2.1 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
8.2.2 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
8.2.3 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
8.3 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
8.3.1 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
8.3.2 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
8.3.3 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
9.2 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
9.2.1 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
9.2.2 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
9.2.3 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
9.3 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
9.3.1 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
9.3.2 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
9.3.3 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
9.4 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region
9.4.1 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2019-2024)
9.4.3 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
10.2.1 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
10.3.1 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
10.4.1 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.1.4 Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.1.5 Eli Lilly Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.2.4 Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.3.4 Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.3.5 Bayer Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.4.4 Novartis AG Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.4.5 Novartis AG Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.5.4 Merck Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.5.5 Merck Recent Developments
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Details
11.6.2 GlaxoSmithKline plc Business Overview
11.6.3 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.6.4 GlaxoSmithKline plc Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.6.5 GlaxoSmithKline plc Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.7.4 Roche Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.7.5 Roche Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.8.4 AstraZeneca Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.8.5 AstraZeneca Recent Developments
11.9 BaiYunShan General Factory
11.9.1 BaiYunShan General Factory Company Details
11.9.2 BaiYunShan General Factory Business Overview
11.9.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.9.4 BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.9.5 BaiYunShan General Factory Recent Developments
11.10 SK Chemicals
11.10.1 SK Chemicals Company Details
11.10.2 SK Chemicals Business Overview
11.10.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.10.4 SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.10.5 SK Chemicals Recent Developments
11.11 Teva Pharma
11.11.1 Teva Pharma Company Details
11.11.2 Teva Pharma Business Overview
11.11.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.11.4 Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.11.5 Teva Pharma Recent Developments
11.12 Dong-A ST
11.12.1 Dong-A ST Company Details
11.12.2 Dong-A ST Business Overview
11.12.3 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.12.4 Dong-A ST Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.12.5 Dong-A ST Recent Developments
11.13 Metuchen Pharma
11.13.1 Metuchen Pharma Company Details
11.13.2 Metuchen Pharma Business Overview
11.13.3 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.13.4 Metuchen Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.13.5 Metuchen Pharma Recent Developments
11.14 Seoul Pharma
11.14.1 Seoul Pharma Company Details
11.14.2 Seoul Pharma Business Overview
11.14.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.14.4 Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.14.5 Seoul Pharma Recent Developments
11.15 Vectura Group
11.15.1 Vectura Group Company Details
11.15.2 Vectura Group Business Overview
11.15.3 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.15.4 Vectura Group Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.15.5 Vectura Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Avanafil
1.2.5 Vardenafil
1.3 Market by Application
1.3.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Perspective (2019-2030)
2.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Trends by Region
2.2.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Region (2019-2024)
2.2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (2025-2030)
2.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Dynamics
2.3.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Trends
2.3.2 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
2.3.3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
2.3.4 Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Phosphodiesterase Type 5 (PDE5) Inhibitor by Players
3.1.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (2019-2024)
3.1.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Players (2019-2024)
3.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio
3.4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2023
3.5 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor Head office and Area Served
3.6 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Product and Application
3.7 Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Type
4.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Type (2019-2024)
4.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2025-2030)
5 Phosphodiesterase Type 5 (PDE5) Inhibitor Breakdown Data by Application
5.1 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Historic Market Size by Application (2019-2024)
5.2 Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
6.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
6.2.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
6.2.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
6.2.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
6.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
6.3.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
6.3.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
6.3.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
6.4 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
6.4.1 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024)
6.4.3 North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
7.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
7.2.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
7.2.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
7.2.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
7.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
7.3.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
7.3.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
7.3.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
7.4 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
7.4.1 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024)
7.4.3 Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
8.2 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
8.2.1 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
8.2.2 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
8.2.3 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
8.3 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
8.3.1 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
8.3.2 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
8.3.3 China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
9.2 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
9.2.1 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
9.2.2 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
9.2.3 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
9.3 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
9.3.1 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
9.3.2 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
9.3.3 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
9.4 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region
9.4.1 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2019-2024)
9.4.3 Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type
10.2.1 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application
10.3.1 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country
10.4.1 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.1.4 Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.1.5 Eli Lilly Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.2.4 Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.3.4 Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.3.5 Bayer Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.4.4 Novartis AG Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.4.5 Novartis AG Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.5.4 Merck Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.5.5 Merck Recent Developments
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Details
11.6.2 GlaxoSmithKline plc Business Overview
11.6.3 GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.6.4 GlaxoSmithKline plc Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.6.5 GlaxoSmithKline plc Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.7.4 Roche Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.7.5 Roche Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.8.4 AstraZeneca Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.8.5 AstraZeneca Recent Developments
11.9 BaiYunShan General Factory
11.9.1 BaiYunShan General Factory Company Details
11.9.2 BaiYunShan General Factory Business Overview
11.9.3 BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.9.4 BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.9.5 BaiYunShan General Factory Recent Developments
11.10 SK Chemicals
11.10.1 SK Chemicals Company Details
11.10.2 SK Chemicals Business Overview
11.10.3 SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.10.4 SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.10.5 SK Chemicals Recent Developments
11.11 Teva Pharma
11.11.1 Teva Pharma Company Details
11.11.2 Teva Pharma Business Overview
11.11.3 Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.11.4 Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.11.5 Teva Pharma Recent Developments
11.12 Dong-A ST
11.12.1 Dong-A ST Company Details
11.12.2 Dong-A ST Business Overview
11.12.3 Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.12.4 Dong-A ST Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.12.5 Dong-A ST Recent Developments
11.13 Metuchen Pharma
11.13.1 Metuchen Pharma Company Details
11.13.2 Metuchen Pharma Business Overview
11.13.3 Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.13.4 Metuchen Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.13.5 Metuchen Pharma Recent Developments
11.14 Seoul Pharma
11.14.1 Seoul Pharma Company Details
11.14.2 Seoul Pharma Business Overview
11.14.3 Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.14.4 Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.14.5 Seoul Pharma Recent Developments
11.15 Vectura Group
11.15.1 Vectura Group Company Details
11.15.2 Vectura Group Business Overview
11.15.3 Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Introduction
11.15.4 Vectura Group Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
11.15.5 Vectura Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Sildenafil
Table 3. Key Players of Tadalafil
Table 4. Key Players of Avanafil
Table 5. Key Players of Vardenafil
Table 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2019-2024)
Table 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2025-2030)
Table 12. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Trends
Table 13. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
Table 14. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
Table 15. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
Table 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Players (2019-2024)
Table 18. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2023)
Table 19. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Headquarters and Area Served
Table 22. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Product and Application
Table 23. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2019-2024)
Table 27. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2025-2030)
Table 29. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Application (2019-2024)
Table 31. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Application (2025-2030)
Table 33. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 65. Eli Lilly Company Details
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 68. Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 69. Eli Lilly Recent Developments
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 73. Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 74. Pfizer Recent Developments
Table 75. Bayer Company Details
Table 76. Bayer Business Overview
Table 77. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 78. Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 79. Bayer Recent Developments
Table 80. Novartis AG Company Details
Table 81. Novartis AG Business Overview
Table 82. Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 83. Novartis AG Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 84. Novartis AG Recent Developments
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 88. Merck Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 89. Merck Recent Developments
Table 90. GlaxoSmithKline plc Company Details
Table 91. GlaxoSmithKline plc Business Overview
Table 92. GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 93. GlaxoSmithKline plc Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 94. GlaxoSmithKline plc Recent Developments
Table 95. Roche Company Details
Table 96. Roche Business Overview
Table 97. Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 98. Roche Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 99. Roche Recent Developments
Table 100. AstraZeneca Company Details
Table 101. AstraZeneca Business Overview
Table 102. AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 103. AstraZeneca Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 104. AstraZeneca Recent Developments
Table 105. BaiYunShan General Factory Company Details
Table 106. BaiYunShan General Factory Business Overview
Table 107. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 108. BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 109. BaiYunShan General Factory Recent Developments
Table 110. SK Chemicals Company Details
Table 111. SK Chemicals Business Overview
Table 112. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 113. SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 114. SK Chemicals Recent Developments
Table 115. Teva Pharma Company Details
Table 116. Teva Pharma Business Overview
Table 117. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 118. Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 119. Teva Pharma Recent Developments
Table 120. Dong-A ST Company Details
Table 121. Dong-A ST Business Overview
Table 122. Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 123. Dong-A ST Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 124. Dong-A ST Recent Developments
Table 125. Metuchen Pharma Company Details
Table 126. Metuchen Pharma Business Overview
Table 127. Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 128. Metuchen Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 129. Metuchen Pharma Recent Developments
Table 130. Seoul Pharma Company Details
Table 131. Seoul Pharma Business Overview
Table 132. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 133. Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 134. Seoul Pharma Recent Developments
Table 135. Vectura Group Company Details
Table 136. Vectura Group Business Overview
Table 137. Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 138. Vectura Group Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 139. Vectura Group Recent Developments
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type: 2023 VS 2030
Figure 3. Sildenafil Features
Figure 4. Tadalafil Features
Figure 5. Avanafil Features
Figure 6. Vardenafil Features
Figure 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Other Case Studies
Figure 13. Phosphodiesterase Type 5 (PDE5) Inhibitor Report Years Considered
Figure 14. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region: 2023 VS 2030
Figure 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Players in 2023
Figure 18. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2023
Figure 20. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 22. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 23. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2019-2030)
Figure 24. United States Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 28. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 29. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2019-2030)
Figure 30. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 38. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 39. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 41. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 42. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2019-2030)
Figure 43. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2019-2030)
Figure 53. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Eli Lilly Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 60. Pfizer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 61. Bayer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 62. Novartis AG Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 63. Merck Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 64. GlaxoSmithKline plc Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 65. Roche Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 66. AstraZeneca Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 67. BaiYunShan General Factory Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 68. SK Chemicals Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 69. Teva Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 70. Dong-A ST Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 71. Metuchen Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 72. Seoul Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 73. Vectura Group Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Table 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Sildenafil
Table 3. Key Players of Tadalafil
Table 4. Key Players of Avanafil
Table 5. Key Players of Vardenafil
Table 6. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2019-2024)
Table 10. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2025-2030)
Table 12. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Trends
Table 13. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Drivers
Table 14. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Challenges
Table 15. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Restraints
Table 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Players (2019-2024)
Table 18. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2023)
Table 19. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Headquarters and Area Served
Table 22. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Product and Application
Table 23. Global Key Players of Phosphodiesterase Type 5 (PDE5) Inhibitor, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2019-2024)
Table 27. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Market Share by Type (2025-2030)
Table 29. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Application (2019-2024)
Table 31. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue Share by Application (2025-2030)
Table 33. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 65. Eli Lilly Company Details
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 68. Eli Lilly Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 69. Eli Lilly Recent Developments
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 73. Pfizer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 74. Pfizer Recent Developments
Table 75. Bayer Company Details
Table 76. Bayer Business Overview
Table 77. Bayer Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 78. Bayer Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 79. Bayer Recent Developments
Table 80. Novartis AG Company Details
Table 81. Novartis AG Business Overview
Table 82. Novartis AG Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 83. Novartis AG Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 84. Novartis AG Recent Developments
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 88. Merck Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 89. Merck Recent Developments
Table 90. GlaxoSmithKline plc Company Details
Table 91. GlaxoSmithKline plc Business Overview
Table 92. GlaxoSmithKline plc Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 93. GlaxoSmithKline plc Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 94. GlaxoSmithKline plc Recent Developments
Table 95. Roche Company Details
Table 96. Roche Business Overview
Table 97. Roche Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 98. Roche Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 99. Roche Recent Developments
Table 100. AstraZeneca Company Details
Table 101. AstraZeneca Business Overview
Table 102. AstraZeneca Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 103. AstraZeneca Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 104. AstraZeneca Recent Developments
Table 105. BaiYunShan General Factory Company Details
Table 106. BaiYunShan General Factory Business Overview
Table 107. BaiYunShan General Factory Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 108. BaiYunShan General Factory Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 109. BaiYunShan General Factory Recent Developments
Table 110. SK Chemicals Company Details
Table 111. SK Chemicals Business Overview
Table 112. SK Chemicals Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 113. SK Chemicals Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 114. SK Chemicals Recent Developments
Table 115. Teva Pharma Company Details
Table 116. Teva Pharma Business Overview
Table 117. Teva Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 118. Teva Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 119. Teva Pharma Recent Developments
Table 120. Dong-A ST Company Details
Table 121. Dong-A ST Business Overview
Table 122. Dong-A ST Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 123. Dong-A ST Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 124. Dong-A ST Recent Developments
Table 125. Metuchen Pharma Company Details
Table 126. Metuchen Pharma Business Overview
Table 127. Metuchen Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 128. Metuchen Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 129. Metuchen Pharma Recent Developments
Table 130. Seoul Pharma Company Details
Table 131. Seoul Pharma Business Overview
Table 132. Seoul Pharma Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 133. Seoul Pharma Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 134. Seoul Pharma Recent Developments
Table 135. Vectura Group Company Details
Table 136. Vectura Group Business Overview
Table 137. Vectura Group Phosphodiesterase Type 5 (PDE5) Inhibitor Product
Table 138. Vectura Group Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024) & (US$ Million)
Table 139. Vectura Group Recent Developments
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type: 2023 VS 2030
Figure 3. Sildenafil Features
Figure 4. Tadalafil Features
Figure 5. Avanafil Features
Figure 6. Vardenafil Features
Figure 7. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Other Case Studies
Figure 13. Phosphodiesterase Type 5 (PDE5) Inhibitor Report Years Considered
Figure 14. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region: 2023 VS 2030
Figure 17. Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Players in 2023
Figure 18. Global Top Phosphodiesterase Type 5 (PDE5) Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphodiesterase Type 5 (PDE5) Inhibitor as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Phosphodiesterase Type 5 (PDE5) Inhibitor Revenue in 2023
Figure 20. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 22. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 23. North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2019-2030)
Figure 24. United States Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
Figure 27. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 28. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 29. Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2019-2030)
Figure 30. Germany Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
Figure 37. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 38. China Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 39. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
Figure 40. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 41. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 42. Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Region (2019-2030)
Figure 43. Japan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. South Korea Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Taiwan Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. India Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Australia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Type (2019-2030)
Figure 51. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Application (2019-2030)
Figure 52. Middle East, Africa, and Latin America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share by Country (2019-2030)
Figure 53. Brazil Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Mexico Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Turkey Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Israel Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GCC Countries Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Eli Lilly Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 60. Pfizer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 61. Bayer Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 62. Novartis AG Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 63. Merck Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 64. GlaxoSmithKline plc Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 65. Roche Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 66. AstraZeneca Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 67. BaiYunShan General Factory Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 68. SK Chemicals Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 69. Teva Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 70. Dong-A ST Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 71. Metuchen Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 72. Seoul Pharma Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 73. Vectura Group Revenue Growth Rate in Phosphodiesterase Type 5 (PDE5) Inhibitor Business (2019-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232